Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

RaySearch Laboratories: RayStation and RayCare in clinical use with carbon ions at Yonsei Cancer Center in South Korea

Raysearch Laboratories

RaySearch Laboraties AB (publ) announces that Yonsei Cancer Center in South Korea has treated its first patient using RayStation®* and RayCare®* for carbon ion radiation therapy.

The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei Cancer Center uses the RayStation treatment planning system for photon and carbon ion treatment planning and was the first clinic in the Asia-Pacific region to adopt the RayCare oncology information system. Now, the center becomes the first clinic in this region to start clinical operations with RayCare. At Yonsei, RayCare is connected to the Toshiba carbon ion accelerator facility equppiped with two superconducting carbon gantry rooms and one fixed beam line room.

Ik Jae Lee, Director, Yonsei Cancer Center, says: "We are proud to have treated our first patient using RayStation and RayCare. Yonsei was the first carbon-ion therapy center in Korea. We provide our patients with innovative carbon-ion therapy with the most advanced systems for radiation therapy planning and oncology information. We firmly believe that the support and cutting-edge techniques of RaySearch play extremely important roles in making this a reality at Yonsei and in Korea."

Johan Löf, founder and CEO, RaySearch, says: "We are pleased that Yonsei has started clinical treatments with carbon ion therapy using RayStation and RayCare. RaySearch is proud to take part in the field of carbon ion therapy as a leading supplier. We are also pleased to see that our RayCare oncology information system with Yonsei now is in clinical use in Asia."

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.